← Open Payments lookup

JEETENDRA CHAUDHARY: Open Payments

NPI 1407561236 · INVERNESS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$471 in 26 payments from 11 companies in 2025. Trend: 2023 $47 · 2024 $63 · 2025 $471

Food & beverage: $471
CompanyPaymentsAmount
GlaxoSmithKline, LLC.11$187
Amgen Inc.2$40
PFIZER INC.2$36
AstraZeneca Pharmaceuticals LP2$34
Sumitomo Pharma America, Inc.2$32
Dexcom, Inc.1$30
Novo Nordisk Inc2$29
Edwards Lifesciences Corporation1$25
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$23
Viatris Specialty LLC1$21

Products named: TRELEGY ELLIPTA, REPATHA, FARXIGA, GEMTESA, Dexcom G6 Transmitter, Ozempic, CAPLYTA, YUPELRI.

Industry payments across FL — which companies pay providers there.